Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.

Eckardt L. et al, (2021), Endocrine-related cancer, 28, 757 - 772

Silent hypoxaemia in COVID‐19 patients

Simonson TS. et al, (2021), The Journal of Physiology, 599, 1057 - 1065

Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control

Cheng X. et al, (2020), Journal of Clinical Investigation, 130, 2237 - 2251

Systemic silencing of Phd2 causes reversible immune regulatory dysfunction

Yamamoto A. et al, (2019), Journal of Clinical Investigation, 129, 3640 - 3656

Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway

Hodson EJ. et al, (2016), The Journal of Physiology, 594, 1179 - 1195

HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine

Bishop T. and Ratcliffe PJ., (2015), Circulation Research, 117, 65 - 79

Load More